To determine the impact oral Acetazolamide in changing short time intraocular pressure (IOP) fluctuation in intra vitreous bevacizumab injectio
Phase 1
Recruiting
- Conditions
- all of the patients with a eye disease need to intravitreous bevacizumab injection.
- Registration Number
- IRCT20210408050895N1
- Lead Sponsor
- Rasht University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 340
Inclusion Criteria
all of the patients with a eye disease need to intra vitreous bevacizumab injection in amiralmomnin hospital
Exclusion Criteria
patients with a history of glaucoma ¸ glaucoma surgery
scleral buckle ( SB)
deep vitrectomy (Vitx)
iris neovascularization (NI)
history of anti-glaucoma drug
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Intraocular pressure. Timepoint: half an hour before injecting bevacizumab in vitrous and three hours after injection. Method of measurement: Tonometer Asylum Lamp.
- Secondary Outcome Measures
Name Time Method